Direct costs of pediatric diabetes care in Germany and their predictors

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
A IcksR W Holl

Abstract

Cost-of-illness study to evaluate diabetes-related direct costs for the care of diabetic children and adolescents in Germany from the perspective of the statutory health insurance. For all continuously treated patients < 20 years of age from 89 pediatric departments (n = 6437, 52 % male, mean age 12.5 [SD 3.8], diabetes duration 5.2 [3.3] years), diabetes-related hospitalization, ambulatory care, insulin management, glucose self measurement, and treatment with antihypertensive drugs in 2000 were ascertained, as well as metabolic control (HbA1c). Costs per patient-year were calculated in Euros (EUR) based on year 2000 prices. Using multivariate regression, the associations between costs and age, sex, diabetes duration, and metabolic control were evaluated. Mean total costs per patient-year were EUR 2611 (interquartile range 1665 - 2807). Blood glucose self measurement, hospitalization, and insulin accounted for 37 %, 26 %, and 21 % of the costs, respectively, followed by ambulatory care (9 %), injection equipment and glucagon sets (7 %), and treatment with antihypertensive drugs (0.1 %). The total costs were significantly increased for higher age, longer diabetes duration, and higher HbA1c (p < 0.01). The costs for hospitalizati...Continue Reading

Citations

Nov 4, 2006·Administration and Policy in Mental Health·Scott C FlandersJames T McCracken
Nov 19, 2013·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Jörg ReichertMario Rüdiger
Jul 11, 2009·Stroke; a Journal of Cerebral Circulation·Elizabeth PerkinsWarren Lo
Aug 24, 2013·PloS One·Christina BächleUNKNOWN DPV Initiative and the German BMBF Competence Network Diabetes Mellitus
Jan 3, 2007·Medicina clínica·Paloma GonzálezUNKNOWN Grupo de Trabajo para el Estudio del Coste de la Diabetes
Nov 23, 2005·Pediatric Clinics of North America·Michael J HallerDesmond Schatz
Jan 26, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·S von SengbuschV Wagner
Oct 25, 2012·Pediatric Diabetes·Ondrej CinekUNKNOWN SWEET group
Sep 3, 2010·Pediatric Diabetes·Anita K YingRubina A Heptulla
Mar 16, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·C C BächleUNKNOWN German BMBF Competence Network Diabetes Mellitus
Oct 10, 2015·Italian Journal of Pediatrics·Chiara GiorgettiUNKNOWN Study Group for Diabetes of ISPED
Apr 29, 2011·Diabetes Care·Sundar S ShresthaGiuseppina Imperatore
Jul 23, 2016·Pediatric Diabetes·Feneli KarachaliouKyriaki Karavanaki
Nov 30, 2011·Nature Reviews. Endocrinology·Beate KargesReinhard W Holl
Sep 19, 2019·The Journal of Clinical Endocrinology and Metabolism·Lena-Katharina RadermacherGeorge J Kahaly
Jan 4, 2022·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Fabian Simon FrielitzSimone von Sengbusch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.